nach oben

Erschienen in:

04.06.2021 | COVID-19 | Originalien Zur Zeit gratis

Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany

verfasst von: Prof. Dr. Lars-Olof Hattenbach, F.E.B.O., Dr. Peter Heinz, Nicolas Feltgen, Hans Hoerauf, Thomas Kohnen, Siegfried Priglinger, Werner Bachmann, Johannes Rieks, Nicole Eter, Thomas Reinhard

Erschienen in: Die Ophthalmologie | Sonderheft 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Survey by the commission for cross-sectoral ophthalmology, as a joint commission of the German Ophthalmological Society (DOG) and the Professional Association of German Ophthalmologists (BVA) on the effects of the SARS-CoV‑2 pandemic on ophthalmological patient care in Germany.

Methods

Online-based survey.

Results

A total of 1190 questionnaires were (partly) answered. With respect to outpatient care and consultations from 15 March to 15 April 2020, a total of 69 (5.8%) participants indicated unlimited, 756 (63.5%) reduced and 330 (27.7%) emergency care only, independent of the type of institution. Outpatient surgery was restricted to emergency surgery in 68% of clinics, 42.0% of inpatient wards, 45.0% of surgical medical care centers and group practices and 33.0% of private practices. Inpatient procedures were limited to emergency care in 75.0% of inpatient wards and in 71.0% of clinics. With the exception of endophthalmitis (+8.2%), the number of urgent indications and emergencies declined: retinal detachment (−34.8%), perforating eyeball injuries (−7.3%), acute glaucoma (−17.8%), central retinal artery occlusion and anterior ischemic optic neuropathy (−31.0%), others (−30.9%), penetrating keratoplasty and amniotic membrane transplantation (−59.1%). Institutional or professional policy requirements (76.0%) and appointment cancellation by patients (84.0%) were the most common reasons for limitations in ophthalmic patient care.

Conclusion

The initial phase of the pandemic was characterized by a massive reduction in non-urgent conservative and surgical treatment that affected all areas of ophthalmology. Due to intensive care capacities required for COVID-19 patients, inpatient treatment was largely restricted to emergencies. Treatment of ophthalmological patients, including ocular emergencies and urgent treatment, was maintained across all sectors with a (considerable) decrease in the number of cases even in these groups.

Hattenbach LO, Reinhard T, Walter P et al (2020) Crisis management strategies of hospitals during the pandemic. Ophthalmologe 117(7):652–658. https://doi.org/10.1007/s00347-020-01162-x CrossRefPubMedPubMedCentral

Poeran J, Zhong H, Wilson L et al (2020) Cancellation of elective surgery and intensive care unit capacity in New York state: a retrospective cohort analysis. Anesth Analg. https://doi.org/10.1213/ANE.0000000000005083 CrossRefPubMedPubMedCentral

Tonna JE, Hanson HA, Cohan JN et al (2020) Balancing revenue generation with capacity generation: case distribution, financial impact and hospital capacity changes from cancelling or resuming elective surgeries in the US during COVID-19. medRxiv. https://doi.org/10.1101/2020.04.29.20066506 CrossRefPubMedPubMedCentral

Ralli M, Minni A, Candelori F et al (2020) Effects of COVID-19 pandemic on otolaryngology surgery in Italy: the experience of our university hospital. Otolaryngol Head Neck Surg. https://doi.org/10.1177/0194599820928970 CrossRefPubMed

Taha MA, Hall CA, Rathbone RF et al (2020) Rhinologic procedures in the era of COVID-19: health-care provider protection protocol. Am J Rhinol Allergy. https://doi.org/10.1177/1945892420927178 CrossRefPubMed

Gupta A, Arora V, Nair D et al (2020) Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian scenario. Head Neck. https://doi.org/10.1002/hed.26227 CrossRefPubMedPubMedCentral

Boettler T, Newsome PN, Mondelli MU (2020) Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep 2(3):100113 CrossRefPubMedPubMedCentral

CovidSurg Collaborative, Nepogodiev D, Bhangu A (2020) Elective surgery cancellations Due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. https://doi.org/10.1002/bjs.11746 CrossRef

Argenziano M, Fischkoff K, Smith CR (2020) Surgery scheduling in a crisis. N Engl J Med 382:e87 CrossRefPubMed

10.

Diaz A, Sarac BA, Schoenbrunner AR et al (2020) Elective surgery in the time of COVID-19. Am J Surg. https://doi.org/10.1016/j.amjsurg.2020.04.014 CrossRefPubMedPubMedCentral

11.

Karampelias V, Spanidis Y, Kehagias I (2020) Surgical practice and operative surgical strategies during the COVID-19 T pandemic: a commentary. Ann Med Surg 55:47–48 CrossRef

12.

Skalet AH, Allen RC, Shields CL et al (2020) Considerations for the management and triage of ocular oncology cases during the COVID-19 pandemic. Ocul Oncol Pathol 6(3):1–4 CrossRefPubMed

13.

Lazzerini M, Barbi E, Apicella A (2020) Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health 4(5):e10–e11 CrossRefPubMedPubMedCentral

14.

Yıldırım M, Geçer E, Akgül Ö et al (2020) The impacts of vulnerability, perceived risk, and fear on preventive behaviours against COVID-19. Psychol Health Med 3:1–9

15.

Saleem SM, Pasquale LR, Sidoti PA et al (2020) Virtual ophthalmology: telemedicine in a Covid-19 era. Am J Ophthalmol. https://doi.org/10.1016/j.ajo.2020.04.029 CrossRefPubMedPubMedCentral

16.

Wasser LM, Assayag E, Tsessler M et al (2020) Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak. Graefes Arch Clin Exp Ophthalmol 28:1–8

17.

Holt A, Gislason GH, Schou M et al (2020) New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa494 CrossRefPubMed

18.

De Rosa S, Spaccarotella C, Basso C et al (2020) Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 41(22):2083–2088. https://doi.org/10.1093/eurheartj/ehaa409 CrossRefPubMed

19.

Lange SJ, Ritchey MD, Goodman AB et al (2020) Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions - United States, January-May 2020. MMWR Morb Mortal Wkly 69(25):795–800 CrossRef

20.

Zitelny E, Newman N, Zhao D (2020) STEMI during the COVID-19 pandemic - an evaluation of incidence. Cardiovasc Pathol 48:107232 CrossRefPubMedPubMedCentral

21.

Arons MM, Hatfield KM, Reddy SC (2020) Presymptomatic SARS-coV‑2 infections and transmission in a skilled nursing facility. N Engl J Med 382:2081–2090 CrossRefPubMed

22.

Glauser W (2020) Proposed protocol to keep COVID-19 out of hospitals. CMAJ 192(10):E264–E265 CrossRefPubMedPubMedCentral

23.

Olivia Li JP, Shantha J, Wong TY (2020) Preparedness among ophthalmologists: during and beyond the COVID-19 pandemic. Ophthalmology 127(5):569–572 CrossRefPubMed

24.

Xia J, Tong J, Liu M et al (2020) Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV‑2 infection. J Med Virol 92:589–594 CrossRefPubMed

25.

Seah IYJ, Anderson DE, Kang AEZ et al (2020) Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.03.026 CrossRefPubMed

26.

Guan WJ, Ni ZY, Hu Y, Liang WH et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720 PubMed

27.

Lange C, Wolf J, Auw-Haedrich C et al (2020) Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J Med Virol. https://doi.org/10.1002/jmv.25981 CrossRefPubMedPubMedCentral

28.

Lim LW, Yip LW, Tay HW et al (2020) Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol 21:1–10

29.

Breazzano MP, Shen J, Abdelhakim AH et al (2020) New York city COVID-19 resident physician exposure during exponential phase of pandemic. J Clin Invest. https://doi.org/10.1172/JCI139587 CrossRefPubMedPubMedCentral

30.

Van Gerven L, Hellings PW, Cox T et al (2020) Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak. Rhinology 58(3):289–294 PubMed

31.

Arrigo A, Aragona E, Parodi MB et al (2020) Ophthalmology and SARS-coV-2: blind toward those who fight blindness? Eur J Ophthalmol. https://doi.org/10.1177/1120672120929961 CrossRefPubMed

32.

Loon SC, Teoh SC, Oon LL et al (2004) The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 88(7):861–863 CrossRefPubMedPubMedCentral

33.

Heiduschka P, Lauermann JL, Bosche FD, Eter N (2020) (2020). Ein Schutz gegen die Tröpfcheninfektion an der Spaltlampe. Sicherheit für die Augenärzte UND die Patienten. Ophthalmologe 117(4):296–297 CrossRefPubMed

34.

Lange C, Wolf J, Auw-Hädrich C et al (2020) Welche Bedeutung hat die Bindehaut als möglicher Übertragungsweg für eine SARS-Cov-2-Infektion? Ophthalmologe 117:626–630 CrossRefPubMedPubMedCentral

35.

Wacker K, Reinhard T (2020) Spezielle ophthalmologische Schutzmaßnahmen in der COVID-19-Pandemie. Ophthalmologe 117:638–641 CrossRefPubMedPubMedCentral

36.

Singh P, Müller M, Hack D et al (2020) Entwicklung und Implementierung eines Betriebs-konzeptes in einer Universitätsaugenklinik im Rahmen der SARS-CoV-2-Pandemie. Ophthalmologe 117:595–601 CrossRefPubMedPubMedCentral

37.

Korobelnik JF, Loewenstein A, Eldem B et al (2020) Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol 258:1149–1156 CrossRefPubMedPubMedCentral

38.

Wen JC, McCannel CA, Mochon AB, Garner OB (2020) Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 129(12):1551–1554 CrossRef

Titel: Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany
verfasst von: Prof. Dr. Lars-Olof Hattenbach, F.E.B.O.
Dr. Peter Heinz
Nicolas Feltgen
Hans Hoerauf
Thomas Kohnen
Siegfried Priglinger
Werner Bachmann
Johannes Rieks
Nicole Eter
Thomas Reinhard
Publikationsdatum: 04.06.2021
Verlag: Springer Medizin
Schlagwort: COVID-19
Erschienen in: Die Ophthalmologie / Ausgabe Sonderheft 2/2021
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-021-01411-7

Neu im Fachgebiet Augenheilkunde

09.05.2023 | Chekpoint-Inhibitoren | CME

Springer Medizin

Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Okuläre Nebenwirkungen moderner onkologischer Therapie

Diagnostik des okulären Schleimhautpemphigoids

Immunpathogenese des Schleimhautpemphigoids

Erste Ergebnisse des Deutschen okulären Pemphigoid-Registers

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2021

Correlation of in vivo/ex vivo imaging of the posterior eye segment

Erratum zu: Pars-plana-Vitrektomie – von Saug-Schneide-Systemen bis hin zur Ultraschalltechnik

Erratum zu: Amotio-retinae-Versorgung während der Corona-Pandemie

Risk factors for open-angle glaucoma and recommendations for glaucoma screening

Treatment of congenital and early childhood cataract

Erratum zu: Trübung der Intraokularlinse nach kombinierter Katarakt- und minimal-invasiver Glaukomchirurgie (MIGS)

Neu im Fachgebiet Augenheilkunde

Okuläre Nebenwirkungen moderner onkologischer Therapie

Diagnostik des okulären Schleimhautpemphigoids

Immunpathogenese des Schleimhautpemphigoids

Erste Ergebnisse des Deutschen okulären Pemphigoid-Registers